Synthetic
Biology
Automation and
Sequencing
DNA, RNA and
Protein QC
Home > Applications > Bio Engineering
Bio Engineering
If you can conceive it, we can help create it
Innovative ideas require innovative solutions. Decode Science can help you achieve your Bio-Engineering goals like never before
Synthetic
Automation and
DNA, RNA and
Biological engineering is an exciting and rapidly developing field that applies principles from engineering, biology, and other sciences to design and manipulate biological systems for various purposes. It involves the use of tools and techniques to modify living organisms, cells, or molecules to achieve specific goals, such as producing valuable compounds, developing novel therapies, or addressing environmental challenges.
Decode Science offers custom gene and oligo manufacture, CRISPR expertise, quality control and more. At Decode Science, we pride ourselves on the level of flexibility, customisation, and collaboration we bring when working together to come up with a solution that improves outcomes for you.
High-efficiency guide RNAs for knockouts and knock-ins.
CRISPR experts agree that using synthetic single guide RNAs (sgRNAs) for genome engineering generate more efficient and consistent editing results than any other type of guide RNAs.
Synthego sgRNAs are highly pure guides that deliver indel frequencies of up to 99%, making it easy to efficiently conduct knockout or knock-ins in virtually any cell type. Their sgRNAs can be ordered with site-specific chemical modifications that provide greater stability and decreased activation of the cellular innate immune response.
Genetic engineering
Manipulating the genetic material of organisms to introduce, remove, or modify specific genes. This enables the production of desired proteins, modification of metabolic pathways, and creation of genetically modified organisms (GMOs) for various applications.
Synthetic Biology
Designing and constructing biological systems with novel functions not found in nature. This involves assembling standardized genetic parts, circuits, and modules to create biological "machines" for tasks such as biosynthesis, sensing, and computation.
Bioprocess Engineering
Developing and optimising processes for the large-scale production of biomolecules, pharmaceuticals, biofuels, and other bioproducts. This includes designing bioreactors, optimising fermentation conditions, and implementing downstream purification techniques.
Tissue Engineering
Creating functional tissues and organs by combining cells, biomaterials, and bioactive molecules. Tissue engineers aim to regenerate damaged tissues, develop organ replacements, and model disease processes for drug discovery and testing.
Biomedical Engineering
Applying engineering principles to solve biomedical problems, such as designing medical devices, diagnostics, imaging technologies, and prosthetics. This field encompasses a wide range of disciplines, including biomechanics, biomaterials, medical imaging, and neural engineering.
Twist Bioscience
Twist Bioscience, headquartered in South San Francisco, is a prominent biotechnology company specializing in the manufacture of synthetic DNA and DNA products for diverse industries. Established in 2013 by Emily Leproust, Bill Banyai, and Bill Peck, Twist Bioscience has quickly emerged as a leader in the field.
In March 2021, the company was represented by Emily Leproust at a tabletop exercise during the Munich Security Conference. The simulation focused on an outbreak of weaponized monkeypox, showcasing Twist Bioscience's involvement in addressing critical global challenges.
In May 2021, Twist Bioscience collaborated with the Genome Project-Write to launch a groundbreaking Computer-Aided Design (CAD) platform for whole genome design. This innovative platform automates workflows, facilitating collaborative efforts essential for scaling up genome design—from designing plasmids to megabases across entire genomes. This initiative marks a significant advancement in genomic research and underscores Twist Bioscience's commitment to driving progress through technology and collaboration.
LEARN MORE >
MGI
MGI, also known as MGI Tech, is a prominent Chinese biotechnology company specializing in a comprehensive array of products and technologies catering to the genetic sequencing, genotyping, gene expression, and proteomics markets. Headquartered in Shenzhen, China, MGI has established itself as a leading provider of innovative solutions to meet the evolving needs of the biotechnology and life sciences industries. With its diverse product line and cutting-edge technologies, MGI is dedicated to advancing research and applications in genomics and proteomics fields, contributing to scientific breakthroughs and advancements worldwide.
LEARN MORE >
BiOptic
BiOptic, Inc. is a pioneering biotechnology instrument company dedicated to the development, manufacturing, and marketing of fully-integrated systems and tests for Fluorescence Immunoassay analysis across various sectors, including research, clinical, and industrial markets. The cutting-edge systems empower rapid and sophisticated Antibody-Antigen interaction testing, automating complex manual laboratory procedures for enhanced efficiency and accuracy.
The user-friendly systems seamlessly integrate multiple intricate and time-consuming steps, such as sample preparation and detection, streamlining the analysis of complex biological samples. Central to the technology are the proprietary pen-size gel-cartridges, which facilitate the efficient processing of samples within the systems.
LEARN MORE >
Synthego
Synthego is a genome engineering company dedicated to advancing life science research and development for enhanced human health. Leveraging machine learning, automation, and gene editing, Synthego builds scalable platforms for scientific exploration. Rooted in engineering disciplines, its platform technologies seamlessly integrate proprietary hardware, software, bioinformatics, chemistries, and molecular biology. This integration drives progress in basic research, target validation, and clinical trials.
Synthego's technologies have been featured in numerous peer-reviewed publications and are utilized by a multitude of commercial and academic researchers, as well as therapeutic drug developers. By delivering genome editing on an unprecedented scale, Synthego is spearheading innovation in medicine, poised to shape the next generation of treatments.
LEARN MORE >
Let’s Find You an Application That Helps Your Research
Get a call from your local Decode Science representative to help you find the best fit genomics products for you.
- Or give us a call at:
- 1300 581 991